Last update: Nov. 25, 2019

Tobramycin

Very Low Risk for breastfeeding


Safe. Compatible.
Not risky for breastfeeding or infant.

Aminoglycoside antibacterial with actions and uses similar to those of gentamicin.
Administration by intramuscular or intravenous injection, or by inhalation

Excreted into breast milk in non-significant amount (Takase 1975, Uwaydah 1975, Festini 2006) without harm effects observed among breastfed infants of mothers treated with Tobramycin (Festini 2006 y 2004, Bourget 1993).

In addition, a low oral bioavailability renders concentration in the infant's plasma be nil or low.

Be aware of the risk of acute diarrhea by alteration of normal gut flora.

Several experts consider the use of this medication safe during breastfeeding (Hale 2019, Briggs 2017, Rowe 2013, Schaefer 2007, Chin 2001, Niebyl 1992).

When used in eye drops, because of a low dose and topical application with minimal absorption in the serum, it is compatible while breastfeeding.

Alternatives

We do not have alternatives for Tobramycin since it is relatively safe.

Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Other names

Tobramycin is also known as


Tobramycin in other languages or writings:

Pharmacokinetics

Variable Value Unit
Oral Bioavail. 0 %
Molecular weight 468 daltons
Protein Binding 1 %
VD 0,3 l/Kg
Tmax 0,5 - 1,5 hours
T1/2 2 - 3 hours
M/P ratio 0,4 -
Theoretical Dose 0,09 mg/Kg/d
Relative Dose 3 %
Relat.Ped.Dose 1,5 %

References

  1. Hale TW. Hale's Medications & Mothers' Milk. Springer Publishing Company. 2019
  2. Briggs GG, Freeman RK, Towers CV, Forinash AB. Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk. Wolters Kluwer Health. 11th edition (acces on line) 2017
  3. Rowe H, Baker T, Hale TW. Maternal medication, drug use, and breastfeeding. Pediatr Clin North Am. 2013 Feb;60(1):275-94. Abstract
  4. Schaefer C, Peters P, Miller RK. Drugs During Pregnancy and Lactation. Treatment options and risk assessment. Elsevier, second edition. London. 2007
  5. Festini F, Ciuti R, Taccetti G, Repetto T, Campana S, De Martino M. Breast-feeding in a woman with cystic fibrosis undergoing antibiotic intravenous treatment. J Matern Fetal Neonatal Med. 2006 Jun;19(6):375-6. Abstract
  6. Festini F. Ciuti R, Repetto T, Taccetti G, Neri A, Campana S, Mergni G, de Martino M. Safety of breast-feeding during an IV tobramycin course for infants of CF women. Pediatr Pulmonol Suppl. 2004;27:288-9. Poster-Abstract 291. 2004
  7. Chin KG, McPherson CE 3rd, Hoffman M, Kuchta A, Mactal-Haaf C. Use of anti-infective agents during lactation: Part 2--Aminoglycosides, macrolides, quinolones, sulfonamides, trimethoprim, tetracyclines, chloramphenicol, clindamycin, and metronidazole. J Hum Lact. 2001 Feb;17(1):54-65. Abstract
  8. Bourget P, Quinquis-Desmaris V, Fernandez H. Ceftriaxone distribution and protein binding between maternal blood and milk postpartum. Ann Pharmacother. 1993 Abstract
  9. Niebyl JR. Use of antibiotics for ear, nose, and throat disorders in pregnancy and lactation. Am J Otolaryngol. 1992 Jul-Aug;13(4):187-92. Review. No abstract available. Abstract
  10. Fulton B, Moore LL. Antiinfectives in breastmilk. Part II: Sulfonamides, tetracyclines, macrolides, aminoglycosides and antimalarials. J Hum Lact. 1992 Dec;8(4):221-3. Review. No abstract available. Abstract
  11. Uwaydah M, Bibi S, Salman S. Therapeutic efficacy of tobramycin--a clinical and laboratory evaluation. J Antimicrob Chemother. 1975 Abstract
  12. Takasa Z, Shirafuji H, Uchida M et al. Laboratory and clinical studies on tobramycin in the fields of obstetrics and gynecology. Chemotherapy (Tokyo) 1975; 23:1399–1402.

Total visits

46,534

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write to us at elactancia.org@gmail.com

e-lactancia is a resource recommended by Academy of Breastfeeding Medicine from United States of America

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM